International
The Morning Science

What science found today

‹
 

Research

Intravenous phage therapy for difficult-to-treat infections: a systematic review and meta-analysis of individual patient data

Nature · By Fernando Arnaiz Guerrero ·

The Brief

  • A systematic review and meta-analysis pools individual patient data on intravenous phage therapy for difficult-to-treat infections.
  • It synthesises clinical, microbiological and safety outcomes.
  • It also covers pharmacokinetic and immune neutralisation data.

Why it matters

It consolidates patient-level evidence on intravenous phage therapy, which clinicians and researchers can use to judge its clinical, microbiological and safety profile for hard-to-treat infections.

Who’s affected

  • clinicians treating difficult-to-treat infections
  • researchers working on phage therapy

Nature Communications, Published online: 20 November 2026; doi:10.1038/s41467-026-79491-9 This systematic review synthesises evidence on clinical, microbiological and safety outcomes of intravenous phage therapy, together with pharmacokinetic and immune neutralisation data…

Timeline

  1. Published online in Nature Communications

  2. nature.com

    Intravenous phage therapy for difficult-to-treat infections: a systematic review and meta-analysis of individual patient data

How do you feel about this?

0 Comments

    Intravenous phage therapy for difficult-to-treat infections: a systematic review and meta-analysis of individual patient data – The Morning Science